HIV Glasgow 2024

HIV Glasgow 2024

Slim J, et al.

PAIRED ‐PAtIent Reported Experiences and perceiveD benefit of treatment with dolutegravir/lamivudine (DTG/3TC): a sub‐analysis of people with HIV (PWH) switching from bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in the United States

HIV_Glasgow24_P07_2024-11-04
Video Player is loading.
Current Time 0:00
Duration 4:01
Loaded: 0%
Stream Type LIVE
Remaining Time 4:01
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Navigate to: